Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes

Scientific Reports

Volumn 6, Issue , 2016, Pages

  De Gonzalo Calvo, D ^a,b   Kenneweg, F ^b   Bang, C ^b   Toro, R ^c   Van Der Meer, R W ^d   Rijzewijk, L J ^e   Smit, J W ^f   Lamb, H J ^d   Llorente Cortes, V ^a   Thum, T ^b,g  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF CÁDIZ   (Spain)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Cantonal Hospital Baden   (Switzerland)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LONG UNTRANSLATED RNA;

BLOOD; DIAGNOSTIC IMAGING; GENETICS; HEART; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY;

BIOMARKERS; DIABETES MELLITUS, TYPE 2; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RNA, LONG NONCODING; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84996938087     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep37354     Document Type: Article

References (45)

1. Ryden, L. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 34, 3035-3087 (2013).
2. Boudina, S., Abel, E. D. Diabetic cardiomyopathy revisited. Circulation. 115, 3213-3223 (2007).
3. Liu, J. E. et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol. 37, 1943-1949 (2001).
4. Zabalgoitia, M., Ismaeil, M. F., Anderson, L., Maklady, F. A. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol. 87, 320-323 (2001).
5. van der Meer, R. W. et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation. 119, 2069-2077 (2009).
6. Devaux, Y. et al. Long noncoding RNAs in cardiac development and ageing. Nat Rev Cardiol. 12, 415-425 (2015).
7. Thum, T., Condorelli, G. Long Noncoding RNAs and MicroRNAs in Cardiovascular Pathophysiology. Circ Res. 116, 751-762 (2015).
8. Uchida, S., Dimmeler, S. Long Noncoding RNAs in Cardiovascular Diseases. Circ Res. 116, 737-750 (2015).
9. Li, D. et al. Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure. PLoS One. 8, e77938 (2013).
10. Yang, K. C. et al. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation. 129, 1009-1021 (2014).
11. Huang, X. et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 14, 319 (2013).
12. Ounzain, S. et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur Heart J. 36, 353-368a (2015).
13. Kumarswamy, R. et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res. 114, 1569-1575 (2014).
14. Vausort, M., Wagner, D. R., Devaux, Y. Long noncoding RNAs in patients with acute myocardial infarction. Circ Res. 115, 668-677 (2014).
15. Liu, J. Y. et al. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis. 5, e1506 (2014).
16. Yan, B. et al. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 116, 1143-1156 (2015).
17. Carter, G. et al. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBA Clin. 4, 102-107 (2015).
18. Rijzewijk, L. J. et al. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol. 54, 1524-1532 (2009).
19. Rijzewijk, L. J. et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 52, 1793-1799 (2008).
20. van der Meer, R. W. et al. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J. 29, 1516-1522 (2008).
21. Nagueh, S. F. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 10, 165-193 (2009).
22. Devereux, R. B. et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation. 101, 2271-2276 (2000).
23. From, A. M., Scott, C. G., Chen, H. H. Changes in diastolic dysfunction in diabetes mellitus over time. Am J Cardiol. 103, 1463-1466 (2009).
24. Ding, X. Q. et al. Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease. Sci Rep. 5, 14925 (2015).
25. Jiang, Y. et al. Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep. 4, 5026 (2014).
26. Zhou, X., Yin, C., Dang, Y., Ye, F., Zhang, G. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci Rep. 5, 11516 (2015).
27. de Kok, J. B. et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res. 62, 2695-2698 (2002).
28. van de Weijer, T., Schrauwen-Hinderling, V. B., Schrauwen, P. Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res. 92, 10-18 (2011).
29. Bell, R. D. et al. Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol. 34, 1249-1259 (2014).
30. Orn, S. et al. Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J. 30, 1978-1985 (2009).
31. Zampetaki, A., Willeit, P., Drozdov, I., Kiechl, S., Mayr, M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res. 93, 555-562 (2012).
32. Ewing, D. J., Martyn, C. N., Young, R. J., Clarke, B. F. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 8, 491-498 (1985).
33. Jonker, J. T. et al. Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 95, 456-460 (2010).
34. van der Meer, R. W. et al. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes. 56, 2849-2853 (2007).
35. Paelinck, B. P. et al. Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol. 45, 1109-1116 (2005).
36. Puthanveetil, P., Chen, S., Feng, B., Gautam, A., Chakrabarti, S. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med. 19, 1418-1425 (2015).
37. Zhou, L. et al. Long non-coding MIAT mediates high glucose-induced renal tubular epithelial injury. Biochem Biophys Res Commun. 468, 726-732 (2015).
38. Ishii, I. et al. Intimal smooth muscle cells up-regulate beta-very low density lipoprotein-mediated cholesterol accumulation by enhancing beta-very low density lipoprotein uptake and decreasing cholesterol efflux. Biochim Biophys Acta. 1585, 30-38 (2002).
39. Gao, Y. et al. The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res. 42, 13799-13811 (2014).
40. Lee, J. H. et al. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res. 109, 1332-1341 (2011).
41. Carrion, K. et al. The long non-coding HOTAIR is modulated by cyclic stretch and WNT/beta-CATENIN in human aortic valve cells and is a novel repressor of calcification genes. PLoS One. 9, e96577 (2014).
42. Lin, M. et al. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS One. 6, e23356 (2011).
43. Ralfkiaer, U. et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood. 118, 5891-5900 (2011).
44. Lorenzen, J. M. et al. Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. Clin Chem. 61, 191-201 (2015).
45. Levelt, E. et al. Relationship between Left Ventricular Structural and Metabolic Remodelling in Type 2 Diabetes Mellitus. Diabetes. 65, 44-52 (2016).